Canaccord Genuity Reiterates a 'Buy' on Anthera Pharma (ANTH); Looking Ahead to Other B-Mod Programs
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Price: $0.00 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 7
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 7
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Anthera Pharma (NASDAQ: ANTH) price target of $6.00.
Analyst, Ritu Baral, said, "Reiterate rating and price target on blisibimod clinical and commercial potential in lupus. We expect blisibimod, ANTH’s Phase 2 BAFF peptibody for lupus, will yield positive data from the PEARL trial in June and start the Phase 3 Chablis trial in early 2013. ANTH may start Phase 2 blisibimod trials in other lupus-related B cell disorders to leverage market potential and diversify clinical risk. Our $6 target is based on a pNPV analysis."
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $3.17 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating and price target on blisibimod clinical and commercial potential in lupus. We expect blisibimod, ANTH’s Phase 2 BAFF peptibody for lupus, will yield positive data from the PEARL trial in June and start the Phase 3 Chablis trial in early 2013. ANTH may start Phase 2 blisibimod trials in other lupus-related B cell disorders to leverage market potential and diversify clinical risk. Our $6 target is based on a pNPV analysis."
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $3.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
- First BanCorp (FBP) PT Raised to $21 at Keefe, Bruyette & Woods
- BOK Financial (BOKF) PT Raised to $97 at DA Davidson
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
